Molecular Mechanisms and Probe‐Dependent Effects of Clinically Relevant GABA A Receptor Modulators
Archiv der Pharmazie · 2026-06 · 359 (6)
DOI: 10.1002/ardp.70277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 03.07.2026. Verfasst von Marvin Taterra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical and Medicinal Chemistry, Universität Münster, Münster, Germany. Hauptthemen laut MEDLINE: Receptors, GABA-A, Benzodiazepines, Anesthetics, GABA Modulators. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Modulators of γ‐aminobutyric acid type A (GABA A ) receptor, including benzodiazepines, anaesthetics, and Z‐drugs, act through distinct allosteric mechanisms that remain incompletely understood at the molecular level. Here, we investigate probe‐dependent pharmacology in GABA A receptor modulation by integrating molecular dynamics simulations, deep learning‐based enhanced sampling, dynamic pharmacophores, and our recently developed MDPath approach for mapping allosteric communication networks. We demonstrate that benzodiazepines and Z‐drugs leverage physiological GABA for activity through long‐range allosteric coupling. These modulators bind in the transmembrane domain (TMD), establishing allosteric commmunication to the extracellular domain (ECD) GABA binding sites, stabilizing GABA receptor interactions and explaining their probe‐dependent positive allosteric modulation. In contrast, anaesthetics forms additional interactions that enable direct binding‐driven channel activation independent of GABA, distinguishing ago‐PAMs from PAMs despite binding at the same sites. Remarkably, the flumazenil antidote acts by globally disrupting interdomain allosteric communication, selectively preventing the action of ECD‐dependent modulators (benzodiazepines and Z‐drugs) while sparing anaesthetics' direct effects. Our integrated computational approach reveals the structural determinants of receptor state transitions, providing a framework for understanding probe‐dependent pharmacology in ligand‐gated ion channels with implications for rational drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical and Medicinal Chemistry, Universität Münster, Münster, Germany.
- GRK 2515, Chemical Biology of Ion Channels (Chembion), Universität Münster, Münster, Germany.
ORCID-Profile: Marvin Taterra, Yuan Chang-Halabi, Marcel Bermúdez
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Taterra, M., Chang-Halabi, Y., & Bermúdez, M. (2026). Molecular Mechanisms and Probe‐Dependent Effects of Clinically Relevant GABA A Receptor Modulators. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70277
Vancouver
Taterra M, Chang-Halabi Y, Bermúdez M. Molecular Mechanisms and Probe‐Dependent Effects of Clinically Relevant GABA A Receptor Modulators. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70277
BibTeX
@article{Taterra2026,
author = {Taterra, Marvin and Chang-Halabi, Yuan and Bermúdez, Marcel},
title = {Molecular Mechanisms and Probe‐Dependent Effects of Clinically Relevant GABA A Receptor Modulators},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {6},
doi = {10.1002/ardp.70277}
}
EUVIMED